Sign In

What's New

Jul 20
The U.S. Food and Drug Administration has approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.
Jul 18
Recent guidelines are right to recommend screening high risk patients for cirrhosis, say liver specialists Mark Hudson at Freeman Hospital, Newcastle upon Tyne, and Nick Sheron at Southampton General...
Jul 13
A new study has revealed that bile duct cells can switch to become normal liver cells to help repair the liver after severe damage.

Member Spotlight

Christina Lindenmeyer, MD

My development as an academic physician began with an introduction to basic science research and has grown into a dedication to the practice of evidence-based medicine.